Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parag Tolat

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Surgery|February 27, 2024
Median arcuate ligament release at the time of pancreaticoduodenectomy or total pancreatectomyErin P Ward, Stephanie Vincent-Sheldon, Parag Tolat, et al.
Familial Cancer|November 5, 2017
Development of a high risk pancreatic screening clinic using 3.0 T MRIChad A Barnes, Elizabeth Krzywda, Shannon Lahiff, et al.
Surgery|January 15, 2018
Locally advanced pancreas cancer: Staging and goals of therapyNikolaos A Chatzizacharias, Susan Tsai, Michael Griffin, et al.
Annals of Surgery|August 7, 2018
A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal AdenocarcinomaSusan Tsai, Kathleen K Christians, Ben George, et al.
Frontiers in Oncology|May 5, 2020
Value of Pretreatment <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant TherapyChad A Barnes, Mohammed Aldakkak, Callisia N Clarke, et al.
Surgery|July 6, 2019
Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgeryChad A Barnes, Mariana I Chavez, Susan Tsai, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Surgery|February 27, 2024
Median arcuate ligament release at the time of pancreaticoduodenectomy or total pancreatectomyErin P Ward, Stephanie Vincent-Sheldon, Parag Tolat, et al.
Familial Cancer|November 5, 2017
Development of a high risk pancreatic screening clinic using 3.0 T MRIChad A Barnes, Elizabeth Krzywda, Shannon Lahiff, et al.
Surgery|January 15, 2018
Locally advanced pancreas cancer: Staging and goals of therapyNikolaos A Chatzizacharias, Susan Tsai, Michael Griffin, et al.
Annals of Surgery|August 7, 2018
A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal AdenocarcinomaSusan Tsai, Kathleen K Christians, Ben George, et al.
Frontiers in Oncology|May 5, 2020
Value of Pretreatment <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant TherapyChad A Barnes, Mohammed Aldakkak, Callisia N Clarke, et al.
Surgery|July 6, 2019
Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgeryChad A Barnes, Mariana I Chavez, Susan Tsai, et al.
Pageof 2